Salvia implants first patient with neuromodulation device fo

A woman in Nambour, Australia, is the first patient to receive a minimally invasive implantable neuromodulation device for severe migraine and cluster headache in a first-in-human study conducted by Salvia Bioelectronics BV.

Related Keywords

Australia , Nambour , Queensland , , Salvia Bioelectronics , Helmholtz Diabetes Center , Cachexia , Cancer Induced Cachexia , Penx Acip , Neuromodulation , Migraine , Salvia Bioelectronics Bv , Theranica Bio Electronics Ltd , Cluster Headaches , Electrocore Inc , Neurolief Ltd ,